CSTL
CSTL
NASDAQ · Health Care

Castle Biosciences Inc

$32.75
+0.35 (+1.08%)
As of Feb 8, 1:44 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -44.5% upside
Low Target $12.18
Average Target $18.16
High Target $26.24
Current Price $32.75
Current
$32.75
Target
$18.16
$12.18 $18.16 avg $26.24
Scenario Analysis
Bear Case
$12.18
-62.8%
Low target
Base Case
$18.16
-44.5%
Avg target
Bull Case
$26.24
+-19.9%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$44.28
-26.0% from high
52-Week Low
$14.59
+124.5% from low
Target vs 52W High
$18.16
-59.0% vs high
Next Earnings Report
Feb 26, 2026 · After Market Close
9d
until earnings
EPS Est: $-0.28
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +11.4%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -55.0%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.6%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.3%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +78.8%